QTS logo

IQVIA Holdings XTRA:QTS Stock Report

Last Price


Market Cap







16 Nov, 2022


Company Financials +

QTS Stock Overview

Engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.

QTS fundamental analysis
Snowflake Score
Future Growth4/6
Past Performance5/6
Financial Health1/6

IQVIA Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IQVIA Holdings
Historical stock prices
Current Share PriceUS$231.45
52 Week HighUS$250.50
52 Week LowUS$187.70
11 Month Change0%
3 Month Change0%
1 Year Change-1.51%
33 Year Changen/a
5 Year Changen/a
Change since IPO49.32%

Recent News & Updates

Recent updates

Shareholder Returns

QTSDE Life SciencesDE Market

Return vs Industry: QTS exceeded the German Life Sciences industry which returned -23.6% over the past year.

Return vs Market: QTS underperformed the German Market which returned 4.7% over the past year.

Price Volatility

Is QTS's price volatile compared to industry and market?
QTS volatility
QTS Average Weekly Movementn/a
Life Sciences Industry Average Movement6.2%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.7%
10% least volatile stocks in DE Market2.5%

Stable Share Price: QTS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine QTS's volatility change over the past year.

About the Company

n/a85,000Ari Bousbibwww.iqvia.com

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc. Fundamentals Summary

How do IQVIA Holdings's earnings and revenue compare to its market cap?
QTS fundamental statistics
Market cap€40.11b
Earnings (TTM)€1.14b
Revenue (TTM)€13.77b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QTS income statement (TTM)
Cost of RevenueUS$9.34b
Gross ProfitUS$4.97b
Other ExpensesUS$3.79b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date


Earnings per share (EPS)6.36
Gross Margin34.72%
Net Profit Margin8.26%
Debt/Equity Ratio231.8%

How did QTS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.